I did promise not to reveal the identity of Teva’s Lovenox developer while it is not yet in the public domain, but I think those days are numbered. With what’s been said on this board and a few educated guesses, the answer ought to be within reach of someone with a modicum of sleuthing ability.
This is material information that should have been made public through TEVA's 10K filings.